Decreased heart rate variability (HRV) has been associated with an increased risk of atherosclerosis. We hypothesized that a decrease in frequency domains of resting HRV would be associated with elevated plasma levels of interleukin (IL)-6 and soluble tissue factor (sTF) both previously shown to prospectively predict atherothrombotic events in healthy subjects. Subjects were 102 healthy and unmedicated black and white middle-aged men and women. We determined IL-6 and sTF antigen in plasma and HRV measures from surface electrocardiogram data using spectral analysis. All statistical analyses controlled for age, gender, ethnicity, smoking status, blood pressure, and body mass index. Low amounts of low frequency (LF) power (b=À0.31, p = 0.007) and high frequency (HF) power (b = À0.36, p = 0.002) were associated with increased amounts of IL-6, explaining 7% and 9% of the variance, respectively. Interactions between LF power and IL-6 (p = 0.002) and between HF power and IL-6 (p = 0.012) explained 8% and 5%, respectively, of the variance in sTF. Post hoc analyses showed associations between IL-6 and sTF when LF power (b = 0.51, p < 0.001) and HF power (b = 0.48, p < 0.001) were low but not when LF power and high HF power were high. The findings suggest that systemic low-grade inflammatory activity is associated with a decrease in HRV. Furthermore, there was a positive relationship between plasma levels of IL-6 and sTF antigen when HRV was low. Inflammation and related hypercoagulability might particularly contribute to atherothrombotic events in a setting of decreased HRV.
Introduction
An imbalance in the autonomic nervous system (ANS) as reflected by reduced heart rate variability (HRV) has been associated with atherosclerotic diseases (Thayer and Lane, 2007) . Decreased HRV predicted progression of coronary atherosclerosis (Huikuri et al., 1999) , increased risk of acute coronary events (Tsuji et al., 1996) , and death from coronary artery disease (CAD) (Tsuji et al., 1996) . Atherosclerosis is predominately an inflammatory disease (Ross, 1999) . Because the vagus nerve inhibits production of proinflammatory cytokines in peripheral tissues via a cholinergic anti-inflammatory pathway (Tracey, 2002) , one mechanism that could link decreased HRV with atherosclerosis is by kindling low-grade systemic inflammation (Gidron et al., in press; Thayer and Lane, 2007) . In accordance with this notion, HRV was inversely associated with circulating levels of the proinflammatory cytokine interleukin (IL)-6 in patients with chronic kidney disease (Psychari et al., 2005) , CAD (Janszky et al., 2004) , and decompensated chronic heart failure (Aronson et al., 2001 ). IL-6 plays a central role in the pathogenesis of CAD morbidity and mortality by promoting atherosclerotic plaque proliferation and instability, thereby ultimately increasing the risk
